The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-1 inhibitor (sintilimab) and lenvatinib plus TACE-HAIC as conversion therapy for initially unresectable HCC: A single-arm, phase 2 clinical trial (PLATIC).
 
Yunfei Yuan
No Relationships to Disclose
 
Jiliang Qiu
No Relationships to Disclose
 
Zhenkun Huang
No Relationships to Disclose
 
Wei He
No Relationships to Disclose
 
Yichuan Yuan
No Relationships to Disclose
 
Chenwei Wang
No Relationships to Disclose
 
Binkui Li
No Relationships to Disclose